Clinical Trials Sponsored by Medtronic Diabetes

Total 5446 results

Medtronic Diabetes
Medtronic

Completed

Use of iPro™2 in Real Life Diabetes Management of Type 2 Patients in India

Diabetes Mellitus, Type 2

India
Medtronic Diabetes

Recruiting

Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System and Control at Home

Type 1 Diabetes

United States, Spain, New Zealand, Canada, France, Germany, Italy, Sweden, United Kingdom
Medtronic Diabetes

Completed

Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System

Type 1 Diabetes Mellitus

United States
Medtronic Diabetes

Completed

ADvanced Hybrid Closed Loop Study in Adult Population With Type 1 Diabetes (ADAPT)

Type 1 Diabetes

France, United Kingdom, Germany
Medtronic Diabetes

Completed

A Pivotal Study to Evaluate Guardian™ Connect CGM System Performance in China

Diabetes Mellitus

China
Medtronic Diabetes

Completed

A Pivotal Study to Evaluate Enlite™ Sensor Performance With iPro™2 in China

Diabetes Mellitus

China
Medtronic Diabetes

Terminated

Qingdao: Insulin Pump Follow-Up Program

Type 1 Diabetes

China
Medtronic Diabetes

Completed

CareLink Connect - Technical Evaluation Study

Diabetes Mellitus

Denmark, Netherlands
Medtronic Diabetes

Completed

A Performance Evaluation of the Enlite Glucose Sensor to Support a Full 144 Hours(6Days) of Use

Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus

United States
Medtronic Diabetes

Completed

OpT2mise Glucose Control in Type 2 Diabetes Mellitus (DM) With Insulin Pump Therapy (OpT2mise)

Diabetes Mellitus, Type 2

United States, France, Germany, Austria, Canada, Hungary, Israel, Italy, Macedonia, The Former Yugoslav Republic of, Netherlands, Serbia, South Africa, Spain
Medtronic Diabetes

Completed

User Evaluation of the MiniMed 640G Insulin Pump

Type 1 Diabetes | Type 2 Diabetes

United Kingdom, Australia
Medtronic Diabetes

Completed

Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature (ASPIRE)

Type 1 Diabetes

United States
Medtronic Diabetes

Completed

An Inpatient Evaluation of Six-Day Subcutaneous Glucose Sensor Performance (6-DayFU)

Diabetes

United States
Medtronic Diabetes

Completed

Feasibility Study for Training Pump Naïve Subjects To Use The Paradigm® System And Evaluate Effectiveness (STAR2)

Type 1 Diabetes

United States
Medtronic Diabetes

Completed

Effectiveness Study of the Guardian RT in Type 1 Diabetics

Type 1 Diabetes Mellitus

Slovenia, United Kingdom, France, Germany, Israel, Italy, Sweden
Medtronic Diabetes

Active, not recruiting

Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®

Type 1 Diabetes

United States, Canada, Australia
Medtronic Diabetes

Active, not recruiting

Evaluation of the MiniMed 780 System in Paediatric Subjects (LENNY)

Diabetes type1 | Children, Only

Italy, United Kingdom, Finland, Slovenia
Medtronic Diabetes

Completed

Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM

Type 1 Diabetes

United States
Medtronic Diabetes

Completed

InPen User Experience

Diabetes Type 1

Sweden
Medtronic Diabetes

Completed

Evaluation of Meal Gesture Dosing in Adults With Type 1 Diabetes

Type 1 Diabetes

Israel
Medtronic Diabetes

Completed

Impact of Acetaminophen on Performance of Guardian™ Sensor (3) in Adults

Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus

United States
Medtronic Diabetes

Completed

United Kingdom User Evaluation, MiniMed Paradigm® X54 System (X54User)

Diabetes Mellitus, Type 1

United Kingdom
Medtronic Diabetes

Completed

The MiniMed™ 780G Glycemic Control and Quality of Life Study for the Treatment of Pediatric and Adult Subjects With Type 1 Diabetes in France.

Type 1 Diabetes

France
Medtronic Diabetes

Completed

MiniMed™ 670G System China Study for Type I Diabetic

Diabetes Mellitus, Type 1

China
Medtronic Diabetes

Completed

Performance Evaluation of an Advanced Algorithm With CGM in Adults, Adolescents, and Pediatrics

Type 1 Diabetes Mellitus | Type2 Diabetes Mellitus

United States
Medtronic Diabetes

Completed

New Glucose Sensor Pediatric

Type 1 Diabetes Mellitus

United States
Medtronic Diabetes

Completed

Study of MiniMed™ 640G Insulin Pump With SmartGuard™ in Prevention of Low Glucose Events in Adults With Type 1 Diabetes (SMILE)

Type 1 Diabetes

Netherlands, France, Italy, United Kingdom
Medtronic Diabetes

Completed

The Guardcontrol Trial: Study to Assess if Type 1 Diabetics Can Improve Using the Real-time Values of Guardian RT

Diabetes Mellitus

France, Germany, Israel, Italy, Slovenia, Sweden, United Kingdom
Medtronic Diabetes

Completed

Overnight Closed Loop Study in U.S. (OCL)

Type 1 Diabetes

United States
Medtronic Diabetes

Completed

INTERPRET - International Report on Routine Practice of Sensor-enabled Pump Therapy

Diabetes Mellitus, Type 1

Denmark, Spain, Belgium, Serbia, Sweden, Austria, France, Hungary, Israel, Italy, Lithuania, Poland, Slovakia, Slovenia
Medtronic Diabetes

Completed

Registry of Use and Application of Sensor Augmented Pump (SAP) Therapy Under Daily Life Conditions (RANSuP)

Diabetes Mellitus, Type 1
Medtronic Diabetes

Completed

CEP249 Pediatric Accuracy Study

Insulin Requiring Diabetes

United States
Medtronic Diabetes

Completed

Threshold Suspend in Pediatrics at Home

Type 1 Diabetes

United States
Medtronic Diabetes

Withdrawn

Feasibility Study to Evaluate the Hybrid-Logic Closed Loop System in Type 1 Diabetes (DREAMED)

Type 1 Diabetes
Medtronic Diabetes

Completed

Safety and Effectiveness Study of a Closed Loop System Maintaining Patients' Glucose Levels During an Overnight Period

Type 1 Diabetes

United Kingdom
Medtronic Diabetes

Completed

Adult Accuracy Study of the Enlite 3 Glucose Sensor (E3)

Type 1 Diabetes | Type 2 Diabetes

United States
Medtronic Diabetes

Completed

User Evaluation of the MiniMed 620G and 640G Insulin Pumps

Type 1 Diabetes | Type 2 Diabetes

United Kingdom, Denmark, Australia, Spain
Medtronic Diabetes

Completed

Feasibility Study to Evaluate Safety and Device Performance of the Hospital Glucose Management System (HGMS) (MAHI)

Hyperglycemia

United States
Medtronic Diabetes

Completed

Study Comparing Effectiveness of Intraperitoneal Insulin Administration to Subcutaneous Insulin Administration (MIP310)

Type 1 Diabetes

United States
Medtronic Diabetes

Recruiting

In-Home Study With MiniMed™ 780G Pump Automated Control in Type 2-Evaluation of the AHCL System in Adults With Insulin-requiring Type 2 Diabetes

Type 2 Diabetes Treated With Insulin

United States
Medtronic Diabetes

Completed

Use of the Guardian™ Connect System With Smart Connected Devices

Type 1 Diabetes Mellitus

United States
Medtronic Diabetes

Completed

Evaluation of Updated Continuous Glucose Monitoring (CGM) Form Factor in Adults, Adolescents and Pediatrics

Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus

United States, China
Medtronic Diabetes

Completed

Feasibility Studies of Personalized Closed Loop

Type 1 Diabetes

United States
Medtronic Diabetes

Completed

Safety Evaluation of the Hybrid Closed Loop (HCL) System in Pediatric Subjects With Type 1 Diabetes

Type 1 Diabetes

United States, Israel
Medtronic Diabetes

Completed

Evaluation of Extended Wear Infusion Set (EWIS) in Patients With Type 1 Diabetes

Diabetes

United States
Medtronic Diabetes

Withdrawn

A Performance Evaluation of the Harmony 1 Sensors in Adults and Pediatrics

Type 1 Diabetes | Type 2 Diabetes
Medtronic Diabetes

Completed

Feasibility Study of New Subcutaneous Glucose Sensor With Recording Devices

Type 1 Diabetes | Type 2 Diabetes

United States
Medtronic Diabetes

Completed

SWITCH - Sensing With Insulin Pump Therapy to Control HbA1c (SWITCH)

Diabetes Mellitus, Type 1

Netherlands, Slovenia, Denmark, Austria, Italy, Luxembourg, Spain
Medtronic Diabetes

Completed

Hybrid Closed Loop Pivotal Trial in Type 1 Diabetes

Type 1 Diabetes

United States, Israel
Medtronic Diabetes

Completed

Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data

Diabetes

United States

Clinical Trials Sponsored by Medtronic Diabetes

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Serbia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations